Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palovarotene in pediatric multiple osteochondromas
NCT03442985Phase 2Terminated
- Sponsor
- Clementia Pharmaceuticals Inc.
- Start
- Mar 2018
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 12
01
Overview
A Phase 2 trial of palovarotene in multiple osteochondromas (HMO), sponsored by Clementia Pharmaceuticals Inc.. Started Mar 2018; status: terminated.
02
Drugs
palovarotene
03
Conditions
multiple osteochondromas (HMO)
Beyond the preview
Go deeper on NCT03442985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03442985.